| Followers | 200 |
| Posts | 25584 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Thursday, March 03, 2022 2:45:03 PM
No, the lease is primarily for hotel suite (fancy way to say office space) and computer areas and corridors, with lab and cryogenic space being relatively small. So you don’t really have enough information to suggest this.
The reality is they are a contract manufacturer, they run the factory and are given some space in the same factory to have their offices and to symbiotically run their own business as well.
In exchange they pay approximately 1.5 to 2 times whatever NWBO pays for the leased space. But nothing in that lease says they own or have leased control over the spaces developed specifically for NWBO under contract.
Of course they will have space there to conduct some of their own business but the spaces are designated and relatively small in comparison to the overall picture.
Try to spin it all you want but you’re not really showing anything, you’re just piddling around in a pretty basic lease agreement and trying to make more of it than is there to your false claims.
As for the overall agreement, as I have said before, it is and has always been indicated to be a quite straightforward, commercial contract like they had with Cognate. However, the spaces developed under contract and on behalf of NWBO are subject to specific work contracts and belong to NWBO and it is cancelable at any time, with 12 months transfer time. Clearly the parties would have to work out the issues with Advent and the subleased space if such an unlikely event happened, but the reality, which you don’t want to accept is that they are a contract manufacturer, and the only likely other circumstance would be NWBO or a buyer taking over the license to conduct the manufacturing entirely on their own upon full operation, and Advent could continue having leased space there to do its own business, or such buyer might buy their lease out. Not a particularly surprising result.
The reality is they are a contract manufacturer, they run the factory and are given some space in the same factory to have their offices and to symbiotically run their own business as well.
In exchange they pay approximately 1.5 to 2 times whatever NWBO pays for the leased space. But nothing in that lease says they own or have leased control over the spaces developed specifically for NWBO under contract.
Of course they will have space there to conduct some of their own business but the spaces are designated and relatively small in comparison to the overall picture.
Try to spin it all you want but you’re not really showing anything, you’re just piddling around in a pretty basic lease agreement and trying to make more of it than is there to your false claims.
As for the overall agreement, as I have said before, it is and has always been indicated to be a quite straightforward, commercial contract like they had with Cognate. However, the spaces developed under contract and on behalf of NWBO are subject to specific work contracts and belong to NWBO and it is cancelable at any time, with 12 months transfer time. Clearly the parties would have to work out the issues with Advent and the subleased space if such an unlikely event happened, but the reality, which you don’t want to accept is that they are a contract manufacturer, and the only likely other circumstance would be NWBO or a buyer taking over the license to conduct the manufacturing entirely on their own upon full operation, and Advent could continue having leased space there to do its own business, or such buyer might buy their lease out. Not a particularly surprising result.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
